K-numberK250113
Device nameneoLaser Laser Surgery Fibers
ApplicantG.N.S Neolaser , Ltd.
Product codeGEX
Device classClass II
Decision dateMar 13, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The neoLaser Laser Surgery Fibers are sterile, single-use fiber optic devices that deliver laser energy to soft tissue in contact and non-contact modes for surgical applications. They transmit energy from a laser system to treatment sites and can be used via endoscopes or cytoscopes across multiple surgical specialties including general surgery, urology, dermatology, vascular surgery, and plastic surgery.

Technological characteristics

Both the subject and predicate devices share identical technical specifications: silica quartz glass core with optional Hardclad cladding, wavelength range 450–2100 nm, core diameter 200–1000 μm, maximal laser power 100W, shelf life 5 years, SMA 905 connectors, sterilization by ethylene oxide, and single-use sterile double-pouched packaging. Fiber tip types include flat, conical, ball, spherical, or bent bare fibers with outer diameters from 1.0–1.8 mm.

Test standards cited

Not stated in this summary. The submission references packaging seal strength, dye penetration, microbial barrier testing, shelf-life validation, sterilization process validation, endotoxin testing (LAL), bioburden testing, biocompatibility testing, and thermal safety validation, but no specific consensus standards (ISO, IEC, ASTM) are cited.

Substantial equivalence argument

The neoLaser fibers are substantially equivalent because they are identical in design, materials, performance characteristics, indications for use, and technical specifications to the predicate BeaMed fibers (K232769). Both devices transmit laser energy across the same wavelength range using identical fiber construction, operate in the same contact and non-contact modes, support the same maximum power and wavelength specifications, and are indicated for the same surgical applications. Performance testing demonstrates equivalent safety and effectiveness profiles, eliminating any meaningful differences in intended use or technological function.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →